On Tuesday, Shares of Itaú Unibanco Holding S.A. (NYSE:ITUB), gained 2.38% to $7.73, hitting its lowest level. The firm has current market cap of 46.87B and on average over the past 3 months has seen 14733400 shares trade hands on a daily basis.
The stock has received a short-term price target of $12.17. The share price can be predictable to fluctuate from the mean short-term target; can be seen from the standard deviation reading of $12.45. The higher estimate of target price is $13.59, while the lower price target estimate is $10.60.
Itaú Unibanco Holding S.A. provides various financial products and services to individuals and corporate clients in Brazil and internationally. The company operates through Commercial Bank Retail, Consumer Credit Retail, and Wholesale Bank segments.
Shares of Bristol-Myers Squibb Company (NYSE:BMY), inclined 1.28% to $64.28, during its last trading session.
R-PHARM US declares the acquisition of IXEMPRA (ixabepilone) from Bristol-Myers Squibb (BMY). IXEMPRA received marketing approval from the U.S. Food and Drug Administration in 2007 and in 18 other markets globally. IXEMPRA is indicated as monotherapy or in combination with capecitabine for the treatment of metastatic or locally advanced breast cancer in patients whose tumors are resistant or refractory to anthracyclines, taxanes, and capecitabine. With the acquisition, R-PHARM US has launched its U.S. commercial operations, and it is now responsible for all activities surrounding IXEMPRA’s manufacture, distribution, sales, and reimbursement. Financial terms were not revealed.
“IXEMPRA is an important therapy in treating metastatic or locally advanced breast cancer, and we are excited to position IXEMPRA as the cornerstone of our product portfolio,” stated Mark Pavao, President and Chief Executive Officer of R-PHARM US. “Advanced breast cancer patients have limited therapeutic options, and we are committed to ensuring physicians and patients have access to IXEMPRA. When we launch our sales force in October, IXEMPRA will have the support it needs in the physician’s office, and we will work to ensure IXEMPRA continues to have broad formulary and reimbursement coverage.”
OrbiMed of New York, NY, offered financial support and Dechert LLP of Washington, DC, served as legal advisor to R-PHARM US.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
Finally, American Express Company (NYSE:AXP), ended its last trade with 0.30% gain, and closed at $81.24.
Driven by the passionate personality of its New York audience, hard courts and intense competition, the US Open is considered one of the most electric events in all of sports. As part of its sponsorship of the 2015 US Open, American Express (AXP) will place Card Members and tennis fans attending the tournament at the USTA Billie Jean King National Tennis Center and those following along at home at the center of this passionate competition.
The highlight of American Express’ onsite Fan Experience will be ‘You vs. Sharapova,’ a game using virtual reality technology which allows fans to compete against international tennis star Maria Sharapova. Complementing the onsite experience, American Express will bring the excitement and competitive tension behind the game to people watching at home through daily US Open-themed #AmexTennis debates on Twitter with professionals John Isner and Monica Puig.
Sharapova will be the face of American Express at the US Open this year. “The US Open is an electric event and American Express does a fantastic job engaging fans in the sport in new ways at the tournament year after year,” said Maria Sharapova. “I was thrilled when American Express approached me with the ‘You vs. Sharapova’ experience idea. American Express’s history with the US Open and in creating amazing experiences for Card Members like me made it an ideal fit.” In addition to the US Open, she will be involved in American Express projects throughout the year.
In its 21st year as a US Open sponsor, American Express continues to deliver unparalleled experiences improved by the latest technology in addition to exceptional services to Card Members and fans at the Open.
American Express Company, together with its auxiliaries, provides charge and credit payment card products and travel-related services to consumers and businesses worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
